Granted Patent
B2
US 10,959,989 · App. 16/866,995 · Granted Mar 30, 2021
Estrogen receptor modulators
Inventors:
Peter Qinhua Huang (San Diego, CA); Deborah Helen Slee (Encinitas, CA); Sayee Gajanan Hegde (San Diego, CA); Chad Daniel Hopkins (San Diego, CA); Kevin Duane Bunker (Escondido, CA); Joseph Robert Pinchman (San Diego, CA); Rakesh Kumar Sit (San Diego, CA)
Assignee:
Recurium IP Holdings, LLC
A61K31/438A61K31/437A61P5/30A61P35/00C07B59/002C07C69/732C07C69/738C07C69/757C07D209/10C07D471/04C07C2603/62
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.
Claims (3)
1. A compound selected from the group consisting of
2. A compound of the following Formula 11-4:
3. A compound of the following Formula 11-5:
Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 7, 2020
From: HUANG, PETER QINHUA; SLEE, DEBORAH HELEN; HEGDE, SAYEE GAJANAN; HOPKINS, CHAD DANIEL; BUNKER, KEVIN DUANE; SIT, RAKESH KUMAR; PINCHMAN, JOSEPH ROBERT
To: KALYRA PHARMACEUTICALS, INC.
Reel/Frame 053138/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 7, 2020
From: KALYRA PHARMACEUTICALS, INC.
To: ZENO ROYALTIES & MILESTONES, LLC
Reel/Frame 053138/0410 →
CHANGE OF NAME
Recorded Jul 7, 2020
From: ZENO ROYALTIES & MILESTONES, LLC
To: RECURIUM IP HOLDINGS, LLC
Reel/Frame 053140/0380 →
Continuity (3)
Division
16086434
Provisional Application
62317254
· Apr 1, 2016